Difference between revisions of "Team:Virginia/Poster"

Revision as of 17:48, 9 November 2020

Manifold: Protein Shells with Encapsulated DNA Scaffolds for Increasing Efficiency of Biosynthetic Pathways

Presented by Team Virginia 2020

Team: J. Ball, V. Gutierrez, C. Haws, A. Kola, S. Link, C. Marino, E. Micklovic, D. Patel, J. Polzin, A. Pradhan, P. Revelli

Advisors: K. G. Kozminski, J. A. Papin

Abstract

The lack of a versatile and reliable way to improve metabolic flux channeling, pathway orthogonality, and product yields is a major impediment to the expanded utilization of biosynthesis for the production of drugs and industrially valuable chemicals. Manifold, a platform technology that addresses this problem, consists of bacterial microcompartments (BMCs) with encapsulated dsDNA scaffolds that sequester and spatially organize, at fixed concentrations, biosynthetic enzymes presented as zinc-finger fusion proteins. Here we deliver the designs for an E. coli cell capable of synthesizing resveratrol using the Manifold platform. The Manifold platform will help lower costs and expand the applications of chemical biosynthesis.

Introduction

Introduce your project and your team's goals.

Inspiration

What inspired your team? What motivated you to work on this particular project?

Problem

What is the problem your team is working to solve? How does it affect the world?

Idea

How are you going to solve the problem? Where did the idea come from?

Section 1

Use this section to explain whatever you would like! Suggestions: Safety, Human Practices, Measurement, etc.

Section 2.1

Use this section to explain whatever you would like! Suggestions: Safety, Human Practices, Measurement, etc.

Section 2.2

Use this section to explain whatever you would like! Suggestions: Safety, Human Practices, Measurement, etc.

Section 3

Use this section to explain whatever you would like! Suggestions: Safety, Human Practices, Measurement, etc.

Results

What did your team achieve? What do you plan to work on moving forward?

References and Acknowledgements

If not already cited in other sections of your poster, what literature sources did you reference on this poster? Who helped or advised you?

@@ Line 39: / Line 39: @@
 				<b>Abstract</b>
 				<br><br>
-				Our project has three aims: to introduce MoClo as an alternative assembly technique to BioBricks, to develop a standardized protocol for the characterization of genetic circuits using flow cytometry, and to share our MoClo Kit with the iGEM community. MoClo is an assembly technique developed by Weber et al., 2011, which involves a multi-way, one-pot digestion-ligation reaction, enabling faster and more efficient construction of genetic circuits. We converted a large subset of BioBricks from the Registry into MoClo Parts using PCR and cloning strategies. We are in the process of building and characterizing various genetic circuits using MoClo Parts, which we will compare to their BioBrick counterparts. A characterization workflow will be shared once this is complete. We also developed a data sheet using Clotho to be included in the Registry of Standard Biological Parts for each Part we characterized to easily share our data with the synthetic biology community.
+				The lack of a versatile and reliable way to improve metabolic flux channeling, pathway orthogonality, and product yields is a major impediment to the expanded utilization of biosynthesis for the production of drugs and industrially valuable chemicals. Manifold, a platform technology that addresses this problem, consists of bacterial microcompartments (BMCs) with encapsulated dsDNA scaffolds that sequester and spatially organize, at fixed concentrations, biosynthetic enzymes presented as zinc-finger fusion proteins. Here we deliver the designs for an E. coli cell capable of synthesizing resveratrol using the Manifold platform. The Manifold platform will help lower costs and expand the applications of chemical biosynthesis.
 			</div>
 		</div>